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Automated Urinalysis Technique Determines Concentration
of Creatine and Creatinine by Colorimetry 
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The problem: 
To develop a continuous urinalysis technique for 
the determination of creatine and creatinine which are 
of interest in the study of muscle wastage in primates. 
Muscle wastage is one of the factors being studied in 
the biosatellite mission as an indicator of the effect of 
weightlessness. Existing urinalysis instruments and 
techniques require more equipment and operations 
than can be reasonably accommodated in a satellite. 
It was necessary to devise smaller equipment and 
simpler techniques. 
The solution: 
Creatinine concentration in urine is determined in 
an aliquot mixture of the urine with alkaline picrate 
by a color reaction. Creatine is determined in a 
second aliquot by first converting it to creatinine by 
heating in an acid solution. The difference ih values 
of the color intensity between the two aliquots repre-
sents the urinary creatine. Electronic circuits produce 
digital signals of the initial creatinine measurement, 
the subsequent measurement, and of the difference
between them and transmits these data by radio to 
ground stations. 
How it's done: 
The analysis is carried out in a modified dual beam 
colorimeter. The cells are illuminated from a common 
source through bandpass filters peaked at 490 milli-
microns. At this wavelength the absorbancy of the 
reaction products is directly proportional to the 
concentration of creatinine. 
The alkaline picrate solution (25% saturated picrate, 
0.25N sodium hydroxide, and 0.45% sodium chloride) 
is first measured in a light cell to determine its ab-
sorbance at 490 millimicrons, arid this measurement is 
then converted to a digital signal. An appropriate 
mixture of urine, hydrochloric -acid, and alkaline 
picrate solution is made in the ratio pump. The ab-
sorbance of this mixture is measured at 490 milli-
microns and this measurement is also converted to a 
digital signal. The difference between the first and 
second measurements represents creatinine concentra-
tion in the urine.
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To determine creatine, an aliquot of urine is mixed 
with hydrochloric acid in the ratio pump as in the 
previous test and is heated at 100°C for 20 minutes 
to convert creatine to creatinine. After the addition of 
alkaline picrate solution, the absorbance of this reac-
tion mixture is also measured at 490 millimicrons. 
The difference between the second and third measure-
ments represents creatine .concentration in the urine. 
The digital data are then applied to a modulator 
which modulates a telemetering transmitter to trans-
mit the data to ground stations by radio. 
Notes: 
1. This technique is extremely simple and requires a 
minimum of steps and equipment and can be 
readily automated. 
2. The technique described here may be adapted for 
use in hospitals for rapid urinalysis to determine 
creatine and creatinine concentration, either on an 
individual test basis or in on-line continuous pa-
tient monitoring techniques.
3. Inquiries concerning this invention may be di-
rected to:
Technology Utilization Officer 
NASA Pasadena Office 
4800 Oak Grove Drive 
Pasadena, California 9.1103 
Reference: B67-10245 
Patent status: 
Inquiries about obtaining rights for the commercial 
use of this invention may be made to NASA, Code 
GP, Washington, D.C. 20546.
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